UNITED THERAPEUTICS CORPORATION

Serial Number 75979014
Registration 2452198
800

Registration Progress

Application Filed
Dec 16, 1997
Under Examination
May 11, 1999
Approved for Publication
Jan 15, 1999
Published for Opposition
Feb 16, 1999
Registered
May 15, 2001

Basic Information

Serial Number
75979014
Registration Number
2452198
Filing Date
December 16, 1997
Registration Date
May 15, 2001
Published for Opposition
February 16, 1999
Renewal Date
May 15, 2021
Drawing Code
3T09

Status Summary

Current Status
Active
Status Code
800
Status Date
May 27, 2021
Registration
Registered
Classes
005

Rights Holder

United Therapeutics Corporation

03
Address
1040 Spring Street
Silver Spring, MD 20910

Ownership History

United Therapeutics Corporation

Original Applicant
03
Washington, DC

United Therapeutics Corporation

Owner at Publication
03
Washington, DC

United Therapeutics Corporation

Original Registrant
03
Silver Spring, MD

Legal Representation

Attorney
Norm J. Rich

USPTO Deadlines

Next Deadline
2137 days remaining
Section 8 & 9 (30-Year) Renewal Due (Based on registration date 2001-05-15)
Due Date
May 15, 2031
Grace Period Ends
November 15, 2031

Application History

29 events
Date Code Type Description
May 27, 2021 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 27, 2021 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
May 27, 2021 RNL2 Q REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
May 27, 2021 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Feb 22, 2021 E89R I TEAS SECTION 8 & 9 RECEIVED
May 15, 2020 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
May 6, 2011 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
May 6, 2011 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
May 5, 2011 E89R I TEAS SECTION 8 & 9 RECEIVED
Jun 12, 2007 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
May 9, 2007 E815 I TEAS SECTION 8 & 15 RECEIVED
May 9, 2007 815F I REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Nov 6, 2006 CFIT O CASE FILE IN TICRS
May 15, 2001 R.PR A REGISTERED-PRINCIPAL REGISTER
Jan 26, 2001 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 7, 2000 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 6, 2000 CNFR S FINAL REFUSAL MAILED
Apr 13, 2000 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 15, 2000 CNRT S NON-FINAL ACTION MAILED
Feb 1, 2000 DPCC D DIVISIONAL PROCESSING COMPLETE
Feb 1, 2000 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Jul 23, 1999 IUAF S USE AMENDMENT FILED
May 11, 1999 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
Feb 16, 1999 PUBO A PUBLISHED FOR OPPOSITION
Jan 15, 1999 NPUB O NOTICE OF PUBLICATION
Nov 5, 1998 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 14, 1998 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 31, 1998 CNRT F NON-FINAL ACTION MAILED
Aug 12, 1998 DOCK D ASSIGNED TO EXAMINER

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of chronic conditions, namely, chronic heart disease, chronic lung disease, chronic vascular disease
First Use Anywhere: Dec 8, 1997
First Use in Commerce: Dec 8, 1997

Additional Information

Other
The lining shown in the drawing is a feature of the mark and is not intended to indicate color.

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"THERAPEUTICS CORPORATION"